| Accession Number: | 0001562180-21-005501 |
| Date: | 2021-08-18 |
| Issuer: | INARI MEDICAL, INC. (NARI) |
| Original Submission Date: |
HILL, MITCH C.
C/O INARI MEDICAL, INC.
9 PARKER, SUITE 100
IRVINE, CA 92618
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | 2021-08-18 | M | 20,000 | a | $0.46 | 87,946 | direct | ||
| COMMON STOCK | 2021-08-18 | 0 | $0.00 | 1,600 | indirect |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| STOCK OPTIONS (RIGHT TO BUY) | 0.457 | 2021-08-18 | deemed execution date | M | 20,000 (d) | 2029-04-23 | common stock 20,000 | $0.46 | 266,977 | direct |
| ID | footnote |
|---|---|
| f1 | options vested with respected with 25% of the underlying shares on april 30,2020 and vest with respect to the remaining shares in 36 equal monthly installment there after. |
